GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Ending Cash Position

Hamlet BioPharma AB publ (XSAT:HAMLET B) Ending Cash Position : kr20.03 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ Ending Cash Position?

Hamlet BioPharma AB publ's Ending Cash Position for the quarter that ended in Mar. 2025 was kr20.03 Mil.

Hamlet BioPharma AB publ's quarterly Ending Cash Position increased from Sep. 2024 (kr16.54 Mil) to Dec. 2024 (kr30.42 Mil) but then declined from Dec. 2024 (kr30.42 Mil) to Mar. 2025 (kr20.03 Mil).

Hamlet BioPharma AB publ's annual Ending Cash Position declined from Jun. 2022 (kr39.61 Mil) to Jun. 2023 (kr18.39 Mil) but then increased from Jun. 2023 (kr18.39 Mil) to Jun. 2024 (kr23.10 Mil).

Hamlet BioPharma AB publ Ending Cash Position Historical Data

The historical data trend for Hamlet BioPharma AB publ's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ Ending Cash Position Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.24 7.47 39.61 18.39 23.10

Hamlet BioPharma AB publ Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.58 23.10 16.54 30.42 20.03

Hamlet BioPharma AB publ Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hamlet BioPharma AB publ's Ending Cash Position for the fiscal year that ended in Jun. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=18.393+4.708
=23.10

Hamlet BioPharma AB publ's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=30.416+-10.389
=20.03

Hamlet BioPharma AB publ Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hamlet BioPharma AB publ Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Ending Cash Position
Comparable Companies
OSTO:IBT B OSTO:FLUO OSTO:SYNACT OSTO:MAGLE OSTO:ONCO OSTO:CANTA OSTO:ACE OSTO:IRLAB A OSTO:XBRANE OSTO:EGTX VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Website
http://www.hamletpharma.com
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines